Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer

PURPOSE: To analyse if BCG treatment leads to long-term reduction of recurrence, progression, and cancer-specific mortality (CSM) in patients with high-risk NMIBC. MATERIALS AND METHODS: 140 patients with high-risk NMIBC were drawn from a population-based cohort of 538 patients with newly diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiel, Tomas, Ryk, Charlotta, Renström-Koskela, Lotta, Steineck, Gunnar, Schumacher, Martin C., Wiklund, N. Peter, de Verdier, Petra J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510863/
https://www.ncbi.nlm.nih.gov/pubmed/29905887
http://dx.doi.org/10.1007/s00345-018-2375-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510863/
https://www.ncbi.nlm.nih.gov/pubmed/29905887
http://dx.doi.org/10.1007/s00345-018-2375-7

Ejemplares similares